Wednesday, January 13, 2021

Investorideas.com - Cannabis Stock News: Namaste Technologies (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) Continues Upward Revenue Trend, Reporting Estimated Q4 Revenue and Fiscal 2020

Investorideas.com - Cannabis Stock News: Namaste Technologies (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) Continues Upward Revenue Trend, Reporting Estimated Q4 Revenue and Fiscal 2020

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry January 4th - January 8th, 2021

Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry January 4th - January 8th, 2021

Investor Ideas #Potcasts 516, #Cannabis News and #Stocks on the Move; (TSX: $HEXO.TO) (NYSE: $HEXO) (OTCQX: $INLB) (CSE: $TRUL.C) (CSE: $AGRA.C)

Investor Ideas #Potcasts 516, #Cannabis News and #Stocks on the Move; (TSX: $HEXO.TO) (NYSE: $HEXO) (OTCQX: $INLB) (CSE: $TRUL.C) (CSE: $AGRA.C)

 


Delta, Kelowna, BC, January 13, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/011321-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/01131HEXO-INLB-TRUL-AGRA.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public company announcements.

 

Truss CBD USA, a joint venture between HEXO Corp (TSX: HEXO) (NYSE: HEXO) and Molson Coors Beverage Company (NYSE: TAP), today announced the U.S. launch of VeryvellTM, a new line of non-alcoholic, sparkling CBD beverages, exclusively available in Colorado.

 

VeryvellTM is a hemp-derived, adaptogenic, sparkling CBD water now available to Colorado-based consumers in three flavours: Focus (Grapefruit Tarragon), Mind & Body (Strawberry Hibiscus) and Unwind (Blueberry Lavender). VeryvellTM is Powered by HEXOTM, the recognized quality and innovation behind award-winning products.

 

“We are excited to launch VeryvellTM in Colorado through Truss CBD USA, in collaboration with our partner, Molson Coors. Our joint venture with Molson Coors Canada saw Truss Beverage Brands become the number one choice for consumers in Canada and we are expecting similarly great results in the US.” said HEXO CEO and co-founder Sebastien St-Louis. “We have near-term plans to invest additional capital in the USA to support Truss CBD USA and to further execute on our Powered by HEXOTM strategy with other potential CPG partners, outside of beverages, with whom we are currently in ongoing negotiations.”

 

VeryvellTM is produced and distributed within Colorado state lines following the state’s established regulatory framework for hemp-derived CBD in food and beverages and is exclusively distributed by Coors Distributing Company. Truss CBD USA is distinct from Truss Beverages, Molson Coors and HEXO’s joint venture in Canada that focuses on non-alcoholic, cannabis-infused beverages.

 

Item 9 Labs Corp. (OTCQX: INLB), a vertically integrated cannabis operator that produces premium products, today reported the Company's operating and financial results for the fiscal year (FY) ended September 30, 2020.

 

Key Financial Highlights for FY 2020

       Revenue increased 65% to $8.1 million

       Gross profit increased 39% to $3.3 million

       Operating loss decreased 46% to $5.4 million

       Operating expenses as a percentage of gross profit declined from 526% to 265%

       Adjusted EBITDA loss decreased 9% to $2.1 million

Key Business Highlights for FY 2020

       Ramped up cultivation and production operations

       Continued to improve the operating capacity of cultivation and processing facilities

       Signed definitive merger agreement with ONE Cannabis Group

       Named Mike (Mic) Keskey, retired former President of U.S. Retail for Best Buy Co., Inc. (NYSE: BBY), and Doug Bowden, a 30-year consumer electronics veteran with extensive experience in real estate investment and development, to Board of Directors

       Appointed Andrew Bowden as Chief Executive Officer

       Earned one Errl Cup and four 710 Degree Cup awards, Arizona's largest cannabis competitions

       Qualified to trade on OTCQX Market (upgraded from OTC Pink to OTCQB, then from OTCQB to OTCQX, both in August)

 

"This past year has been an exciting and successful time for our team," commented Item 9 Labs Chief Executive Officer Andrew Bowden. "We've seen strong, steady performance with sequential quarter-over-quarter growth rates of nearly 20% since my appointment as CEO at the start of our 2020 fiscal year. Our team continues to exceed expectations and has efficiently ramped production to meet heightened demand for our products, setting the stage for key strategic and operational developments in 2021. We anticipate increased business activities as we continue to pursue opportunities that position the company for growth and profitability."

 

Bowden continued, "We are still in the early stages of our growth and are already seeing an acceleration with Arizona's adult-use marijuana market opening in the first half of 2021, which we estimate will increase our consumer base by 500%. We're prepared to meet this demand through our streamlined production process and by expanding our operational cultivation footprint by more than 300% in the year ahead."

 

"In addition to continued growth in Arizona, we look forward to closing our pending merger with ONE Cannabis Group and their cannabis franchise, Unity Rd. We expect the combination of our premium, award-winning cannabis products with the nation's leading dispensary franchise will elevate our brand footprint through national distribution across Unity Rd.'s locally owned and operated dispensaries. This will ease new market product entry and create recurring revenue streams through franchise royalty fees," Bowden concluded.

 

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company based in the United States, announced today the opening of a brand-new Florida dispensary, the Company's 76th nationwide. The new, 6,000 sq. ft. location marks the Company's 2nd in Gainesville, broadening patient access to Florida's largest and broadest assortment of medical cannabis products.

 

The new dispensary also supports Trulieve's goal of expanding and ensuring direct, reliable access to medical cannabis across its home state of Florida. It joins the Company's 70 other dispensaries statewide, including the original Gainesville location and those in nearby Ocala and Lake City.

 

"2020 presented challenges, but Trulieve focused on patient-driven customer service and organic growth to ensure access and product innovation, and that's what our continued focus will be for 2021," said Trulieve CEO Kim Rivers. "We look forward to building relationships with our Truliever community in Gainesville for many years to come."

 

In honor of the Company's brand-new dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new College Park location on opening day. In line with policies adopted statewide, all visitors are required to wear masks for the duration of their dispensary visit. Additionally, only patients and their state-approved caregivers will be allowed inside the waiting room and dispensary at this time.

 

In stores and online, patients will find Florida's largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 71 dispensaries in Florida.

 

To assist patients with ordering, Trulieve has made our entire catalog of products available for online ordering, with in-store pickup and statewide home delivery options available. In addition, patients can schedule a complimentary 30-minute virtual consultation with a Trulieve certified consultant to help navigate questions on products, devices, or to review their doctor's recommendation.

 

Furthermore, to assist with CDC recommendations for social distancing and in compliance with additional company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients, including modifications to the layout of all stores, installation of plexiglass partitions and HEPA air filtration scrubbers in every dispensary, increasing access to masks and sanitizer throughout the store for staff and visitors, utilizing visual aids to direct traffic throughout the store, and increasing the frequency of deep cleanings for all dispensaries.

 

Trulieve is closely monitoring the coronavirus situation and will update store policies as needed to ensure the highest level of safety of our patients and staff. All updates will be shared directly on Trulieve's website as they are enacted.

 

The Office of Medical Marijuana Use recently announced the registry has surpassed 460,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state's overall volume per the Florida Department of Health. To support the state's rapidly growing patient base, there are more than 2,700 registered ordering physicians in the State of Florida.

 

AgraFlora Organics International Inc. (CSE: AGRA) (OTC: AGFAFannounced an update on the Company’s entrance to the edibles market with the completion of the first phase of R&D trials at its Health Canada licensed 51,000-Square-foot fully-automated edibles manufacturing facility in Winnipeg, Manitoba (the “Edibles Facility”).

 

Prior to receiving a standard processing license from Health Canada, AGRA commenced (See press release dated August 27, 2020) cultivating long-term production relationships through Research and Development (“R&D”) trials utilizing the Company’s Health Canada R&D license. The development phase of the R&D trials is now complete and the company has created efficient processes for desired formulations and product varieties and expects to enter the edibles market in Q1 of 2021.

 

James Fletcher, EIC Co-Founder and Operational Manager stated, “Supply contracts continue to move forward with our Licensed Producer relationships, and we are confident that our gummies with consistent and flavourful variants will soon dominate the gummies category. Our family’s 97 years of confectionary experience provides us a solid culture of quality, craftmanship and efficiency to offer a variety of infused gummy products to multiple LP clients at a time.”

 

“The Company believes that their infused cannabis activated pectin and gelatin gummies variants are well timed given the strength of demand for consistent, quality and tasty gummy products. A recent OCS report showed the gummy category carried the highest market share in the edibles segment compared to chocolate and brownie alternatives at 65% with demand expected to continue to rise.” Commented the Agraflora Board of Directors.

 

The Edibles Facility will utilize its current state of the art laboratory set up to produce approximately 60,000 pieces per eight-hour shift and can manage a variety of brands at once given the efficient nature of the automated production line. The facility’s equipment and design allow EIC to easily pivot and provide specific dosing and custom gummies that meet regulatory requirements and customer specifications. These efficiencies also allow AgraFlora to produce saleable products at a lower cost.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others. 

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

 



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Monday, January 11, 2021

Investorideas.com - Marijuana Legalization Central to Cuomo's State of the State Address

Investorideas.com - Marijuana Legalization Central to Cuomo's State of the State Address

Investor Ideas #Potcasts 515, #Cannabis News and #Stocks on the Move: (CSE: $TER.C) (OTCQX: $TRSSF) (NASDAQ: $SNDL)

 



 

Investor Ideas #Potcasts 515, #Cannabis News and #Stocks on the Move: (CSE: $TER.C) (OTCQX: $TRSSF) (NASDAQ: $SNDL)

 

Delta, Kelowna, BC, January 11, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/011121-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/01111TER-TRSSF-SNDL.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public company announcements.

 

Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the January 7th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com.

 

Log in to view the presentations now at: https://bit.ly/3ooTxyI

 

All presentations will be available for 24/7 on-demand replay for 90 days. Investors, advisors and analysts may also download shareholder materials from the "virtual trade booth" for the next three weeks.

 

 

The following companies participated in the conference:

Eastern

ET

NYC

Presenting Company

Ticker(s)

10:00 AM

Acquired Sales Corp.

(OTCQX: AQSP)

10:30 AM

Vireo Health International Inc.

(OTCQX: VREOF | CSE: VREO)

11:00 AM

Aleafia Health Inc.

(OTCQX: ALEAF |TSX: AH)

11:30 AM

Gage Cannabis Co.

(Private Company)

12:00 PM

4Front Ventures Corp.

(OTCQX: FFNTF | CSE: FFNT)

12:30 PM

MariMed Inc.

(OTCQX: MRMD)

1:00 PM

The Valens Company

(OTCQX: VLNCF |TSX: VLNS)

1:30 PM

Clever Leaves International Inc.

(NASDAQ: CLVR, CLVRW)

2:00 PM

Slang Worldwide Inc.

(OTCQB: SLGWF | CSE: SLNG)

2:30 PM

Emerald Bioscience Inc.

(Pink: EMBI)

3:00 PM

Subversive Capital Acquisition Corp.

(OTCQX: SBVCF | NEO: SVC.A.U, SVC.WT.U)

3:30 PM

Tauriga Sciences, Inc.

(OTCQB: TAUG)

4:00 PM

Experion Holdings Ltd.

(OTCQB: EXPFF | TSX-V: EXP)

4:30 PM

HempFusion Wellness Inc.

(TSX: CBD.U)

 

 

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, announced that it has completed the second phase of construction at its cultivation and manufacturing facility located in Boonton, New Jersey (the "Boonton facility"). This phase of construction added approximately 80,000 square feet of indoor cultivation, to the existing on-site greenhouse and post-harvest manufacturing facilities, bringing the Boonton facility's total current footprint to approximately 140,000 square feet. TerrAscend has the ability to further increase the Boonton facility to 240,000 square feet.

 

TerrAscend recently received approval from the New Jersey Department of Health ("NJ DOH") to commence cultivation activities within the new indoor facility and expects to complete its first indoor harvests in Q1 2021.

 

"The New Jersey cannabis market represents a substantial growth opportunity for TerrAscend. With the completion of this expansion we have significantly scaled up our cultivation footprint to meet current demand," said Jason Ackerman, Executive Chairman of TerrAscend. "I'd like to thank our team for their efforts in completing this project and look forward to increasing the availability of our quality medical products to patients across the state."

 

In August 2020, the Company announced that its approximately 40,000 square foot greenhouse co-located at the Boonton facility was approved by the NJ DOH to begin cultivating cannabis. Concurrently, TerrAscend commenced initial planting of the greenhouse with several harvests completed during Q4 2020. In addition to its current wholesale and retail flower sales, TerrAscend intends to launch its comprehensive suite of high-quality, medical products including pre-rolls, extracted distillate and vaporizable oil, as well as Ilera branded tinctures, topicals and medically-blended vapes.

 

In December 2018, TerrAscend New Jersey was awarded a license to apply for one of six vertically integrated permits. The Company's application received the second highest score of 146 submissions received by the State. After securing additional processing and dispensing approvals, the full permit allows TerrAscend to operate a production facility and up to three Alternative Treatment Centers ("ATCs"), or dispensaries, in the North region of New Jersey. The first Apothecarium-branded ATC opened in Phillipsburg, NJ in Q4 2020, which will be followed by two additional ATCs in the first half of 2021. The Company's Phillipsburg ATC was the state's first in Warren County.

 

Sundial Growers Inc. (Nasdaq: SNDLannounced that it has launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial's focus on premium inhalables, following branded retail offerings of flower, pre-roll and vape cartridges.

 

"We made a strategic decision to produce these premium products based on demand for solventless, flavorful, pure, and potent cannabis concentrates from a growing group of consumers," said Andrew Stordeur, President and Chief Operating Officer of Sundial. "Our control of the entire manufacturing process from cultivation to extraction enables us to deliver premium quality products on a consistent basis. Adding bubble hash and other advanced concentrates to our product portfolio will expand Sundial's share of this rapidly expanding market segment."

 

Sundial has launched a bubble hash product under its Top Leaf brand and will launch other products such as pressed hash and live rosin with capabilities to expand future product offerings through different Sundial brands in the coming quarters.

 

Solventless concentrates from Top Leaf brands are available for purchase in B.C. and Alberta, with plans to be available across the country in the coming months. The Top Leaf brand currently offers Pink Kush and Bubba in the bubble hash format.

 

All Top Leaf concentrate products are produced from high-quality, single-strain, fresh-frozen flower that is produced to preserve its terpene and cannabinoid profile. There are no additives, no fillers and no artificial flavors added to the products.

 

Sundial plans on providing additional offerings in the first quarter of 2021 including Top Leaf's Oregon Golden Goat bubble hash and Grasslands' Sativa & Indica hash.

 

OG DNA Genetics, a globally recognized leading cannabis brand, today announced a partnership agreement with Meristematic, Inc. , a leading cannabis micropropagation and tissue culture provider in California.

 

The Agreement will allow DNA Genetics the ability to provide licensees with clean cultivars and genetically identical starter plants for cultivation with the help of Meristematic’s clean cultivar program. Meristematic’s Clean Cultivar Program uses proprietary tissue culture processes to rejuvenate mother plants while simultaneously filtering out diseases and pests. All new mother stock is thoroughly analyzed, using sensitive molecular techniques, to verify that disease-causing organisms are no longer detectible. Growers then use the rejuvenated mother stock to improve in-house clone production. This program allows cultivators to enjoy some of the benefits of tissue culture, without building a lab or hiring expensive staff to manage a tissue culture program.

 

“DNA is proud to partner with Meristematic to build on its position at the forefront of cannabis innovation as the industry matures. The benefits of tissue culture and genetic marker identification for a cannabis genetic company cannot be overstated,” said Don Morris, Co-Founder and Chief Cannabis Officer of DNA Genetics. “It allows us to provide clean genetics and general propagation services at a commercial scale to all of our cultivation partners across the globe in addition to providing a better understanding of the biological and endocannabinoid makeup of our cultivars.”

 

Since its inception, the genetics developed by DNA has won more than 200 awards, in all categories, at the most prestigious cannabis events around the world – making DNA the global standard in breeding and growing truly best-in-class strains. These awards include the High Times’ Top 10 Strain of the Year, which was inducted into the High Times Seedbank Hall of Fame in 2009, the High Times’ 100 Most Influential People in the Industry, and the High Times’ Trail Blazers Award, for contributions made towards uniting the fields of entrepreneurship, politics, and medicine.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others. 

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory